A subsidiary of California-based Accuray (NSDQ:ARAY) has entered a joint venture with a Chinese company to manufacture and sell radiology oncology systems in China, the companies said today.
Accuray Asia Ltd. will work with Tianjin-based CNNC High Energy Equipment, a subsidiary of China Isotope and Radiation (HKSE:01763). CNNC will own 51% of the joint venture, known as CNNC Accuray (Tianjin) Medical Technology, and Accuray’s subsidiary will own the rest.
